Cachexia is a wasting syndrome characterized by devastating skeletal muscle atrophy that dramatically increases mortality in various diseases, most notably in cancer patients with a penetrance of up to 80%. Knowledge regarding the mechanism of cancer-induced cachexia remains very scarce, making cachexia an unmet medical need. In this study, we discovered strong alterations of iron metabolism in the skeletal muscle of both cancer patients and tumor-bearing mice, characterized by decreased iron availability in mitochondria. We found that modulation of iron levels directly influences myotube size in vitro and muscle mass in otherwise healthy mice. Furthermore, iron supplementation was sufficient to preserve both muscle function and mass, prolong survival in tumor-bearing mice, and even rescues strength in human subjects within an unexpectedly short time frame. Importantly, iron supplementation refuels mitochondrial oxidative metabolism and energy production. Overall, our findings provide new mechanistic insights in cancer-induced skeletal muscle wasting, and support targeting iron metabolism as a potential therapeutic option for muscle wasting diseases.

Iron supplementation is sufficient to rescue skeletal muscle mass and function in cancer cachexia

Wyart E.;Rausch V.;Mezzanotte M.;Penna F.;Hirsch E.;Martini M.;Mazzone M.;Roetto A.;Geninatti Crich S.;Sandri M.;Menga A.;Porporato P. E.
2022-01-01

Abstract

Cachexia is a wasting syndrome characterized by devastating skeletal muscle atrophy that dramatically increases mortality in various diseases, most notably in cancer patients with a penetrance of up to 80%. Knowledge regarding the mechanism of cancer-induced cachexia remains very scarce, making cachexia an unmet medical need. In this study, we discovered strong alterations of iron metabolism in the skeletal muscle of both cancer patients and tumor-bearing mice, characterized by decreased iron availability in mitochondria. We found that modulation of iron levels directly influences myotube size in vitro and muscle mass in otherwise healthy mice. Furthermore, iron supplementation was sufficient to preserve both muscle function and mass, prolong survival in tumor-bearing mice, and even rescues strength in human subjects within an unexpectedly short time frame. Importantly, iron supplementation refuels mitochondrial oxidative metabolism and energy production. Overall, our findings provide new mechanistic insights in cancer-induced skeletal muscle wasting, and support targeting iron metabolism as a potential therapeutic option for muscle wasting diseases.
2022
e53746
e0240632
cachexia; iron; metabolism; mitochondria; muscle
Wyart E.; Hsu M.Y.; Sartori R.; Mina E.; Rausch V.; Pierobon E.S.; Mezzanotte M.; Pezzini C.; Bindels L.B.; Lauria A.; Penna F.; Hirsch E.; Martini M.; Mazzone M.; Roetto A.; Geninatti Crich S.; Prenen H.; Sandri M.; Menga A.; Porporato P.E.
File in questo prodotto:
File Dimensione Formato  
EMBO Reports - 2022 - Wyart - Iron supplementation is sufficient to rescue skeletal muscle mass and function in cancer (1).pdf

Accesso aperto

Tipo di file: PDF EDITORIALE
Dimensione 5.8 MB
Formato Adobe PDF
5.8 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1851321
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 10
  • ???jsp.display-item.citation.isi??? 9
social impact